SCHEMBL8557786

SCHEMBL8557786

COc1c(F)cccc1-c1nc(Cc2ccccc2)oc1-c1ccccc1S(N)(=O)=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37
CA5A P35218 1/20 0.37
CA5B Q9Y2D0 1/20 0.37
RXRA P19793 2/20 0.35
ALDH1A1 P00352 2/20 0.34
MAPT P10636 2/20 0.34
RPS6KA2 Q15349 2/20 0.33
SCN9A Q15858 2/20 0.33
FAAH O00519 1/20 0.32
RXRB P28702 1/20 0.32
PTGS1 P23219 2/20 0.32
PTGS2 P35354 2/20 0.32
PTGES2 Q9H7Z7 1/20 0.32
NMT1 P30419 1/20 0.32
ALOX5AP P20292 2/20 0.32
FEN1 P39748 2/20 0.32
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8559484 0.96 CA12 (0.37) CA12CA1CA2CA9CA5A
SCHEMBL8555989 0.88 NR4A2 (0.38) CA12CA1CA2CA9RXRA
SCHEMBL8560516 0.88 FAAH (0.36) CA12CA1CA2CA9ALDH1A1
SCHEMBL8555128 0.87 MAPT (0.35) CA12CA1CA2CA9RXRA
SCHEMBL8556682 0.87 RPS6KA2 (0.43) CA12CA1CA2CA9RXRA
SCHEMBL7507254 0.87 PTGS2 (0.41) CA12CA1CA2CA9CA5A
SCHEMBL8559668 0.86 ALPL (0.36) CA12CA1CA2CA9RXRA
SCHEMBL8556320 0.85 GRM2 (0.42) CA12CA1CA2CA9RXRA
SCHEMBL8556639 0.85 FAAH (0.36) CA12CA1CA2CA9ALDH1A1
SCHEMBL8556834 0.85 MAPT (0.35) CA12CA1CA2CA9RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5719163-A ARTHRITIS G.D. SEARLE & CO. (US) 1998-02-17 US disclosed
EP-0699192-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-03-06 EP disclosed
WO-1994027980-A1 SUBSTITUTED OXAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1994-12-08 WO disclosed